Despite Patent Windfall, Market Challenges Remain for Generics, Analyst Says

Drug Industry Daily
KEYWORDS generic / Markets
A A

Wall Street’s outlook for generic companies includes increasing generic market penetration and a wave of potentially lucrative patent expirations, but an influx of authorized generics will hurt the profitability now enjoyed by first-to-filers, according to a financial analyst.

To View This Article:

Login

Subscribe To Drug Industry Daily